Related Experiment Video
Updated: Jan 21, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.8K
Multifocal hepatic steatosis mimicking malignancy in two siblings
John Freebody1, Giulio Comin1, Eva Segelov2
1Department of Diagnostic Imaging St Vincent's Public Hospital Sydney New South Wales Australia.
Summary
Multifocal hepatic steatosis (MHS) mimics cancer on imaging, posing diagnostic challenges. This report details two sibling cases, highlighting MHS radiographic features and potential inherited causes.
Area of Science:
- Radiology
- Hepatology
- Medical Imaging
Background:
- Multifocal hepatic steatosis (MHS) is a rare condition characterized by patchy fat accumulation in the liver.
- It can be misdiagnosed as malignant liver disease on imaging studies like ultrasound and CT.
- Accurate differentiation is crucial to avoid unnecessary invasive procedures and patient distress.
Observation:
- Presents two cases of MHS in adult siblings, suggesting a possible genetic link.
- Describes the characteristic radiographic appearances of MHS on imaging.
- Details tips for accurate detection of MHS to differentiate it from malignancies.
Findings:
- MHS nodules vary in size and can mimic hepatocellular carcinoma or metastases.
- Radiographic findings in MHS can be subtle, requiring careful evaluation.
- The sibling presentation suggests a potential inherited pathogenesis for MHS.
Implications:
- Improved diagnostic accuracy for MHS can prevent unnecessary patient investigations, biopsies, and anxiety.
- Recognizing MHS imaging patterns aids radiologists and clinicians in correct diagnosis.
- Further research into the genetic basis of MHS may be warranted given familial occurrences.
Related Concept Videos
01:29Relationship with Other Adult Family Members and Siblings
175
Other adult family members and siblings play a crucial role in shaping children’s social and emotional development. While parents or primary caregivers are often the central figures in early attachment and socialization, other adults in a child’s life, such as grandparents, aunts, and uncles, can significantly influence developmental outcomes. These influences depend on each adult’s personality and may help compensate when a primary caregiver is emotionally distant or...
175
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
259
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
259
01:21Hepatic Portal System
5.5K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.5K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
01:16Hepatic Drug Excretion: Influencing Factors
536
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
536
01:14Hepatic Drug Clearance: Role of Transporters
303
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
303